Stay updated on Venetoclax and Azacitidine in MDS/CMML Clinical Trial
Sign up to get notified when there's something new on the Venetoclax and Azacitidine in MDS/CMML Clinical Trial page.

Latest updates to the Venetoclax and Azacitidine in MDS/CMML Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRevision: v3.3.3 was added to the history, and HHS Vulnerability Disclosure plus Revision: v3.3.2 were removed. These are minor site-wide changes that do not affect the trial record or data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedIn the Record History, Revision: v3.3.2 was added and Revision: v3.2.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check48 days agoChange DetectedThe government funding/operating status notice at the top of the page has been removed. This site-wide message removal does not affect the study details or user actions on the page.SummaryDifference0.7%

- Check62 days agoChange DetectedThe record history now includes more versions with study status and recruitment status updates across multiple dates, expanding the historical changes visible on the page.SummaryDifference0.1%

- Check69 days agoChange DetectedNew version entry on 2025-10-24 adds an updated Study Status in the record history, and the latest version count increases to 14. A prior version dated 2025-09-05 was removed.SummaryDifference0.4%

- Check91 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference12%

Stay in the know with updates to Venetoclax and Azacitidine in MDS/CMML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax and Azacitidine in MDS/CMML Clinical Trial page.